Givastomig Phase 2 Trial Begins in Gastric Cancer
ROCKVILLE, MARYLAND, UNITED STATES — February 17, 2026 NovaBridge announced dosing of the first patient in its global, randomized...
Clinical Research
GLP-1 Therapy Linked to Reduced Asthma Exacerbations
MILWAUKEE, Feb. 15, 2026 — New research presented by the American Academy of Allergy, Asthma & Immunology (AAAAI) reveals...
Ameluz® PDT Phase 3 Trial Meets Primary Endpoint
WOBURN, Mass., Feb. 9, 2026 — Biofrontera Inc. announced positive top-line results from its multicenter Phase 3 clinical trial...
Cancer Facts & Figures 2026 Highlight Progress and Gaps
ATLANTA, Feb. 2 2026 — The latest Cancer Facts & Figures 2026 report highlights the evolving burden of cancer...
Single-Molecule Proteomics Targets Alpha-Synuclein in Parkinson’s
January 28, 2026 — Nautilus Biotechnology, Weill Cornell Medicine–Qatar (WCM-Q), and The Michael J. Fox Foundation (MJFF) have launched...
Myra Vision Treats First Patient in U.S. ADAPT Glaucoma Study
CAMPBELL, CALIFORNIA | January 26, 2026 — Myra Vision, a Shifamed portfolio company, announced that the first patient has...
Finger-Prick Blood Test Could Enable Early Alzheimer’s Diagnosis
London, January 19, 2026 — Scientists from a major international collaboration led by LifeArc and the Global Alzheimer’s Platform...
Nous-209 Vaccine Shows Promise for Cancer Interception
ROME and BASEL, January 2026 — Nouscom has reported compelling clinical evidence supporting the potential of NOUS-209, a neoantigen-directed...
Phase 1 Gene Therapy Data Shows Promise in Stargardt Disease
MALVERN, Pa., January 12, 2026 — Ocugen, Inc. announced the peer-reviewed publication of positive Phase 1 GARDian1 clinical trial...
RNA Methylation Biomarkers Expand Liquid Biopsy Cancer Detection
HEIDELBERG, Germany, December 16, 2025 — Hummingbird Diagnostics GmbH has published a peer-reviewed study revealing a novel approach to...